Synapse - Dean Bajorin

Results (660)

Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection

Journal Article

Thompson, R. H.; Carver, B. S.; Bosl, G. J.; Bajorin, D.; Motzer, R.; Feldman, D.; Reuter, V. E.; Sheinfeld, J.
Urology (2012)

Fulltext@MSK | Save

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design

Journal Article

Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
Cancer (2012)

Fulltext@MSK | Save

Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer

Journal Article

Masterson, T. A.; Shayegan, B.; Carver, B. S.; Bajorin, D. F.; Feldman, D. R.; Motzer, R. J.; Bosl, G. J.; Sheinfeld, J.
Urology (2012)

Fulltext@MSK | Save

Clinical features of germ cell tumors (GCT) in men age 50 or older: Successful outcome and tolerability to chemotherapy for advanced disease

Meeting Abstract

Voss, M. H.; Jacobsen, E. P.; Patil, S.; Turkula, S.; Jia, X.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.; Feldman, D. R.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Final results of a phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium

Meeting Abstract

Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Al-Ahmadie, H.; Ostrovnaya, I.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Association of germ-line variation with platinum-based chemotherapy response in patients (pts) with urothelial carcinoma (UC)

Meeting Abstract

Gallagher, D. J.; Joseph, V.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; Milowsky, M. I.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Design of a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2/neu, in patients with surgically resected urothelial cancer at high risk of recurrence

Meeting Abstract

Bajorin, D. F.; Sharma, P.; Sims, R. B.; Sandler, A.; Lerner, S. P.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC)

Meeting Abstract

Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium

Meeting Abstract

Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Bajorin, D. F.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Defining "cisplatin ineligible" patients with metastatic bladder cancer

Meeting Abstract

Galsky, M. D.; Hahn, N. M.; Rosenberg, J. E.; Sonpavde, G.; Oh, W. K.; Dreicer, R.; Vogelzang, N. J.; Sternberg, C. N.; Bajorin, D. F.; Bellmunt, J.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save